INBIOGEN Co., Ltd. (KRX:101140)

INBIOGEN Revenue

INBIOGEN had revenue of 2.15B KRW in the quarter ending September 30, 2025, with 3.18% growth. This brings the company's revenue in the last twelve months to 7.80B, up 21.25% year-over-year. In the year 2024, INBIOGEN had annual revenue of 7.04B with 12.82% growth.

• Revenue (ttm): 7.80B
• Revenue Growth: +21.25%
• P/S Ratio: 14.97
• Revenue / Employee: 190.33M
• Employees: 41
• Market Cap: 116.82B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.04B	800.26M	12.82%
Dec 31, 2023	6.24B	-4.18B	-40.10%
Dec 31, 2022	10.42B	-61.30M	-0.58%
Dec 31, 2021	10.48B	263.11M	2.58%
Dec 31, 2020	10.22B	422.51M	4.31%